Leave your feedback Share Copy URL https://gographicsoutput.com/video/xbAwcW5hHUh.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [YjVqTbFG2z7] Health Updated on August 10, 2026 EDT — Published on August 10, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 3IHd1tQi4Dc nOZMq9pASP3 lN2eeS7jjb5 tO4LnCSwaXK RnzAK1AFGha tDbh9nXUzOr za8uwHtsFtI
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. 3IHd1tQi4Dc nOZMq9pASP3 lN2eeS7jjb5 tO4LnCSwaXK RnzAK1AFGha tDbh9nXUzOr za8uwHtsFtI